Cx611-0204

· Tigenix S.A.U.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cx611-0204, covering 2022-04-06 to 2022-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Cx611-0204 SEPCELL Study [Phase 1, Phase 2]